OncoSec Medical Inc (ONCSQ)

[jbem777]

Let's see. 1st you have to complete a study to have it peer reviewed. A little DD would show that we are STILL waiting for the results from a number of 2a studies. So the lack of "peer review" is understandable, being that they have nothing to submit because THEY HAVEN'T COMPLETED IT YET.

Also, peer reviewed articles are typically submitted after phase 2b trials have been completed. There is limited interest in safety alone among those in the biotechnology sector, they want to know if the drug/mechanism works, is it effective, and is it safe. The primary goal of 1b/2a studies, which ONCS is currently working on, are safety and dosing, not efficacy.

I know you are new to investing so I am trying to keep it simple for you. But in short, you first have to complete a study before submitting the data for peer review and data for safety trial is not typically reported. Like PVCT or CYTK, most companies wait until after the completion of a P2B to submit data for a peer review.

Hope that helps and keep up the hard work. Happy trading to you.